Abstract CT172: A phase 2 multicenter study to evaluate the efficacy and safety using autologous tumor infiltrating lymphocytes (LN-145) in patients with recurrent metastatic or persistent cervical carcinoma
Year: 2018
Type: conference-abstract
Source: Cancer Research
Institutions: The University of Texas MD Anderson Cancer Center, UPMC Health System, University of Pittsburgh Medical Center, Moffitt Cancer Center, University of Southern California, USC Norris Comprehensive Cancer Center, University of Chicago, The Ohio State University, University of Miami, University of Arizona, University of Arizona College of Medicine- Phoenix, Iovance Biotherapeutics (United States), Roswell Park Comprehensive Cancer Center
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2887834837